ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS


I.T. Murkamilov (1), K.A. Aytbaev (2), F.A. Yusupov (3)

(1) Department of Therapy with a course of Family Medicine KSMA n.a. I.K. Akhunbayev, Bishkek; (2) SRI of Molecular Biology and Medicine at the National Center of Cardiology and Therapy n.a. Acad. M. Mirrakhimov, Bishkek; (3) Department of Neurology and Psychiatry of the Medical Faculty of Osh State University, Osh
This review presents the results of studies showing the need for wider use of angiotensin II receptor blockers in the treatment of socially significant diseases such as type 2 diabetes mellitus, arterial hypertension, cerebrovascular diseases, and chronic kidney disease. The advantages of this class of antihypertensive drugs in relation to their impact on the functional and structural change of the target organs in hypertensive patients are discussed.

About the Autors


I.T. Murkamilov – PhD, Teaching Assistant at the Department of Therapy with a course of Family Medicine KSMA n.a.
I.K. Akhunbayev, Bishkek; e-mail: murkamilov.i@mail.ru


Similar Articles


Бионика Медиа